Global Hemophilia Drugs Market Research Report 2018

Publisher Name :
Date: 07-Aug-2018
No. of pages: 95
Inquire Before Buying

This report studies the global Hemophilia Drugs market status and forecast, categorizes the global Hemophilia Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The hemophilia treatment drugs market is experiencing entry of a large number of new drugs in the market. Few of them have already arrived and other long lasting clotting factors and more promising drugs are on their way to get launched in this market. For instance, follow up data from phase I/II study of hemophilia medicine ‘Emicizumab' by Roche has demonstrated promising results regarding safety and prophylactic efficiency in people with severe hemophilia A. Another example is of ‘Eloctate' for type A and ‘Aprolix' for type B hemophilia, respectively. These two newly arrived biogen products are opposed to commonly prescribe course of three infusions per week as they are longer-acting than traditional treatments and require only one to two infusions per week, due to their new mechanism of action.

With increasing attention on prophylactic treatment, the market for hemophilia drugs is estimated to have a positive outlook over the coming years. The prophylactic treatment approach prevents spontaneous bleeding episodes, significantly improves the quality of life in terms of physical activities, and maintains the level of clotting factors above a baseline. According to the studies conducted by the US National Library of Medicine determined that the savings on prophylactic treatment be approximately USD 8,312 to USD 17,675 per bleeding episode in a person. Moreover, this line of treatment reduces joint damage and suffering from pain. Several of such long-acting therapeutics are under development and expected to be launched over the next four years. The shift in preference for prophylactic treatment due to its advantages will drive this market's growth over the forecast period.

The Americas led the global hemophilia drugs market in 2017 and is expected to continue its dominance until the end of 2023. The Americas have the highest revenue share in the global market with the US contributing to the majority of this revenue. Several countries in the region have introduced health care reforms which are having a positive impact on the market growth. Moreover, healthcare reforms in the US have also helped reduce the cost of pharmaceutical drugs, increased access to healthcare, and improved the overall quality of healthcare. These healthcare reforms are likely to have a positive impact on healthcare insurance and also reduce hospital stay and overall medical expenses, which will boost this market's growth in the region.

The global Hemophilia Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report

- Baxalta

- Bayer

- CSL Behring

- Pfizer

- Alnylam Pharmaceuticals

- BioMarin

- Catalyst Biosciences

- Dimension Therapeutics

- F. Hoffmann-La Roche

- Grifols

- Octapharma

- Sangamo Biosciences

- Spark Therapeutics

- Swedish Orphan Biovitrum

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Hemophilia A

- Inhibitors

- Hemophilia B

- Von Willebrand Disease

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Recombinant Therapies

- Plasma-Derived Therapies

The study objectives of this report are:

- To analyze and study the global Hemophilia Drugs sales, value, status (2013-2017) and forecast (2018-2025).

- Focuses on the key Hemophilia Drugs manufacturers, to study the sales, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Hemophilia Drugs are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Hemophilia Drugs Manufacturers

Hemophilia Drugs Distributors/Traders/Wholesalers

Hemophilia Drugs Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Hemophilia Drugs market, by end-use.

Detailed analysis and profiles of additional market players.

Global Hemophilia Drugs Market Research Report 2018

Table of Contents
Global Hemophilia Drugs Market Research Report 2018
1 Hemophilia Drugs Market Overview
1.1 Product Overview and Scope of Hemophilia Drugs
1.2 Hemophilia Drugs Segment by Type (Product Category)
1.2.1 Global Hemophilia Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Hemophilia Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Hemophilia A
1.2.4 Inhibitors
1.2.5 Hemophilia B
1.2.6 Von Willebrand Disease
1.3 Global Hemophilia Drugs Segment by Application
1.3.1 Hemophilia Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Recombinant Therapies
1.3.3 Plasma-Derived Therapies
1.4 Global Hemophilia Drugs Market by Region (2013-2025)
1.4.1 Global Hemophilia Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Hemophilia Drugs (2013-2025)
1.5.1 Global Hemophilia Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Hemophilia Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Hemophilia Drugs Market Competition by Manufacturers
2.1 Global Hemophilia Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Hemophilia Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Hemophilia Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Hemophilia Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Hemophilia Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Hemophilia Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Hemophilia Drugs Market Competitive Situation and Trends
2.5.1 Hemophilia Drugs Market Concentration Rate
2.5.2 Hemophilia Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Hemophilia Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Hemophilia Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Hemophilia Drugs Production and Market Share by Region (2013-2018)
3.3 Global Hemophilia Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Hemophilia Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Hemophilia Drugs Consumption by Region (2013-2018)
4.2 North America Hemophilia Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Hemophilia Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Hemophilia Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Hemophilia Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Hemophilia Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Hemophilia Drugs Production, Consumption, Export, Import (2013-2018)
5 Global Hemophilia Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Hemophilia Drugs Production and Market Share by Type (2013-2018)
5.2 Global Hemophilia Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Hemophilia Drugs Price by Type (2013-2018)
5.4 Global Hemophilia Drugs Production Growth by Type (2013-2018)
6 Global Hemophilia Drugs Market Analysis by Application
6.1 Global Hemophilia Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Hemophilia Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Hemophilia Drugs Manufacturers Profiles/Analysis
7.1 Baxalta
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Hemophilia Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Baxalta Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Bayer
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Hemophilia Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bayer Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 CSL Behring
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Hemophilia Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 CSL Behring Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Pfizer
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Hemophilia Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Pfizer Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Alnylam Pharmaceuticals
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Hemophilia Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Alnylam Pharmaceuticals Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 BioMarin
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Hemophilia Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 BioMarin Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Catalyst Biosciences
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Hemophilia Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Catalyst Biosciences Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Dimension Therapeutics
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Hemophilia Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Dimension Therapeutics Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 F. Hoffmann-La Roche
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Hemophilia Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 F. Hoffmann-La Roche Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Grifols
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Hemophilia Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Grifols Hemophilia Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 Octapharma
7.12 Sangamo Biosciences
7.13 Spark Therapeutics
7.14 Swedish Orphan Biovitrum
8 Hemophilia Drugs Manufacturing Cost Analysis
8.1 Hemophilia Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hemophilia Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Hemophilia Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hemophilia Drugs Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Hemophilia Drugs Market Forecast (2018-2025)
12.1 Global Hemophilia Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Hemophilia Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Hemophilia Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Hemophilia Drugs Price and Trend Forecast (2018-2025)
12.2 Global Hemophilia Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Hemophilia Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Hemophilia Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Hemophilia Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Hemophilia Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Hemophilia Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Hemophilia Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Hemophilia Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Hemophilia Drugs Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Hemophilia Drugs
Figure Global Hemophilia Drugs Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Hemophilia Drugs Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Hemophilia A
Table Major Manufacturers of Hemophilia A
Figure Product Picture of Inhibitors
Table Major Manufacturers of Inhibitors
Figure Product Picture of Hemophilia B
Table Major Manufacturers of Hemophilia B
Figure Product Picture of Von Willebrand Disease
Table Major Manufacturers of Von Willebrand Disease
Figure Global Hemophilia Drugs Consumption (K MT) by Applications (2013-2025)
Figure Global Hemophilia Drugs Consumption Market Share by Applications in 2017
Figure Recombinant Therapies Examples
Table Key Downstream Customer in Recombinant Therapies
Figure Plasma-Derived Therapies Examples
Table Key Downstream Customer in Plasma-Derived Therapies
Figure Global Hemophilia Drugs Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2013-2025)
Figure North America Hemophilia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Hemophilia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Hemophilia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Hemophilia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Hemophilia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Hemophilia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Hemophilia Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Hemophilia Drugs Capacity, Production (K MT) Status and Outlook (2013-2025)
Figure Global Hemophilia Drugs Major Players Product Capacity (K MT) (2013-2018)
Table Global Hemophilia Drugs Capacity (K MT) of Key Manufacturers (2013-2018)
Table Global Hemophilia Drugs Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Hemophilia Drugs Capacity (K MT) of Key Manufacturers in 2017
Figure Global Hemophilia Drugs Capacity (K MT) of Key Manufacturers in 2018
Figure Global Hemophilia Drugs Major Players Product Production (K MT) (2013-2018)
Table Global Hemophilia Drugs Production (K MT) of Key Manufacturers (2013-2018)
Table Global Hemophilia Drugs Production Share by Manufacturers (2013-2018)
Figure 2017 Hemophilia Drugs Production Share by Manufacturers
Figure 2017 Hemophilia Drugs Production Share by Manufacturers
Figure Global Hemophilia Drugs Major Players Product Revenue (Million USD) (2013-2018)
Table Global Hemophilia Drugs Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Hemophilia Drugs Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Hemophilia Drugs Revenue Share by Manufacturers
Table 2018 Global Hemophilia Drugs Revenue Share by Manufacturers
Table Global Market Hemophilia Drugs Average Price (USD/MT) of Key Manufacturers (2013-2018)
Figure Global Market Hemophilia Drugs Average Price (USD/MT) of Key Manufacturers in 2017
Table Manufacturers Hemophilia Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Hemophilia Drugs Product Category
Figure Hemophilia Drugs Market Share of Top 3 Manufacturers
Figure Hemophilia Drugs Market Share of Top 5 Manufacturers
Table Global Hemophilia Drugs Capacity (K MT) by Region (2013-2018)
Figure Global Hemophilia Drugs Capacity Market Share by Region (2013-2018)
Figure Global Hemophilia Drugs Capacity Market Share by Region (2013-2018)
Figure 2017 Global Hemophilia Drugs Capacity Market Share by Region
Table Global Hemophilia Drugs Production by Region (2013-2018)
Figure Global Hemophilia Drugs Production (K MT) by Region (2013-2018)
Figure Global Hemophilia Drugs Production Market Share by Region (2013-2018)
Figure 2017 Global Hemophilia Drugs Production Market Share by Region
Table Global Hemophilia Drugs Revenue (Million USD) by Region (2013-2018)
Table Global Hemophilia Drugs Revenue Market Share by Region (2013-2018)
Figure Global Hemophilia Drugs Revenue Market Share by Region (2013-2018)
Table 2017 Global Hemophilia Drugs Revenue Market Share by Region
Figure Global Hemophilia Drugs Capacity, Production (K MT) and Growth Rate (2013-2018)
Table Global Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table North America Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Europe Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table China Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Japan Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table China Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Japan Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Global Hemophilia Drugs Consumption (K MT) Market by Region (2013-2018)
Table Global Hemophilia Drugs Consumption Market Share by Region (2013-2018)
Figure Global Hemophilia Drugs Consumption Market Share by Region (2013-2018)
Figure 2017 Global Hemophilia Drugs Consumption (K MT) Market Share by Region
Table North America Hemophilia Drugs Production, Consumption, Import & Export (K MT) (2013-2018)
Table Europe Hemophilia Drugs Production, Consumption, Import & Export (K MT) (2013-2018)
Table China Hemophilia Drugs Production, Consumption, Import & Export (K MT) (2013-2018)
Table Japan Hemophilia Drugs Production, Consumption, Import & Export (K MT) (2013-2018)
Table Southeast Asia Hemophilia Drugs Production, Consumption, Import & Export (K MT) (2013-2018)
Table India Hemophilia Drugs Production, Consumption, Import & Export (K MT) (2013-2018)
Table Global Hemophilia Drugs Production (K MT) by Type (2013-2018)
Table Global Hemophilia Drugs Production Share by Type (2013-2018)
Figure Production Market Share of Hemophilia Drugs by Type (2013-2018)
Figure 2017 Production Market Share of Hemophilia Drugs by Type
Table Global Hemophilia Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Hemophilia Drugs Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Hemophilia Drugs by Type (2013-2018)
Figure 2017 Revenue Market Share of Hemophilia Drugs by Type
Table Global Hemophilia Drugs Price (USD/MT) by Type (2013-2018)
Figure Global Hemophilia Drugs Production Growth by Type (2013-2018)
Table Global Hemophilia Drugs Consumption (K MT) by Application (2013-2018)
Table Global Hemophilia Drugs Consumption Market Share by Application (2013-2018)
Figure Global Hemophilia Drugs Consumption Market Share by Applications (2013-2018)
Figure Global Hemophilia Drugs Consumption Market Share by Application in 2017
Table Global Hemophilia Drugs Consumption Growth Rate by Application (2013-2018)
Figure Global Hemophilia Drugs Consumption Growth Rate by Application (2013-2018)
Table Baxalta Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxalta Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (Baxalta) and Gross Margin (2013-2018)
Figure Baxalta Hemophilia Drugs Production Growth Rate (2013-2018)
Figure Baxalta Hemophilia Drugs Production Market Share (2013-2018)
Figure Baxalta Hemophilia Drugs Revenue Market Share (2013-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bayer Hemophilia Drugs Production Growth Rate (2013-2018)
Figure Bayer Hemophilia Drugs Production Market Share (2013-2018)
Figure Bayer Hemophilia Drugs Revenue Market Share (2013-2018)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure CSL Behring Hemophilia Drugs Production Growth Rate (2013-2018)
Figure CSL Behring Hemophilia Drugs Production Market Share (2013-2018)
Figure CSL Behring Hemophilia Drugs Revenue Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer Hemophilia Drugs Production Growth Rate (2013-2018)
Figure Pfizer Hemophilia Drugs Production Market Share (2013-2018)
Figure Pfizer Hemophilia Drugs Revenue Market Share (2013-2018)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Alnylam Pharmaceuticals Hemophilia Drugs Production Growth Rate (2013-2018)
Figure Alnylam Pharmaceuticals Hemophilia Drugs Production Market Share (2013-2018)
Figure Alnylam Pharmaceuticals Hemophilia Drugs Revenue Market Share (2013-2018)
Table BioMarin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioMarin Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure BioMarin Hemophilia Drugs Production Growth Rate (2013-2018)
Figure BioMarin Hemophilia Drugs Production Market Share (2013-2018)
Figure BioMarin Hemophilia Drugs Revenue Market Share (2013-2018)
Table Catalyst Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Catalyst Biosciences Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Catalyst Biosciences Hemophilia Drugs Production Growth Rate (2013-2018)
Figure Catalyst Biosciences Hemophilia Drugs Production Market Share (2013-2018)
Figure Catalyst Biosciences Hemophilia Drugs Revenue Market Share (2013-2018)
Table Dimension Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dimension Therapeutics Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Dimension Therapeutics Hemophilia Drugs Production Growth Rate (2013-2018)
Figure Dimension Therapeutics Hemophilia Drugs Production Market Share (2013-2018)
Figure Dimension Therapeutics Hemophilia Drugs Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Hemophilia Drugs Production Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Hemophilia Drugs Production Market Share (2013-2018)
Figure F. Hoffmann-La Roche Hemophilia Drugs Revenue Market Share (2013-2018)
Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols Hemophilia Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Grifols Hemophilia Drugs Production Growth Rate (2013-2018)
Figure Grifols Hemophilia Drugs Production Market Share (2013-2018)
Figure Grifols Hemophilia Drugs Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia Drugs
Figure Manufacturing Process Analysis of Hemophilia Drugs
Figure Hemophilia Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hemophilia Drugs Major Manufacturers in 2017
Table Major Buyers of Hemophilia Drugs
Table Distributors/Traders List
Figure Global Hemophilia Drugs Capacity, Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Global Hemophilia Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Hemophilia Drugs Price (Million USD) and Trend Forecast (2018-2025)
Table Global Hemophilia Drugs Production (K MT) Forecast by Region (2018-2025)
Figure Global Hemophilia Drugs Production Market Share Forecast by Region (2018-2025)
Table Global Hemophilia Drugs Consumption (K MT) Forecast by Region (2018-2025)
Figure Global Hemophilia Drugs Consumption Market Share Forecast by Region (2018-2025)
Figure North America Hemophilia Drugs Production (K MT) and Growth Rate Forecast (2018-2025)
Figure North America Hemophilia Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Hemophilia Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Europe Hemophilia Drugs Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Europe Hemophilia Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Hemophilia Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure China Hemophilia Drugs Production (K MT) and Growth Rate Forecast (2018-2025)
Figure China Hemophilia Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Hemophilia Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Japan Hemophilia Drugs Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Japan Hemophilia Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Hemophilia Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Southeast Asia Hemophilia Drugs Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Hemophilia Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Hemophilia Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure India Hemophilia Drugs Production (K MT) and Growth Rate Forecast (2018-2025)
Figure India Hemophilia Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Hemophilia Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Table Global Hemophilia Drugs Production (K MT) Forecast by Type (2018-2025)
Figure Global Hemophilia Drugs Production (K MT) Forecast by Type (2018-2025)
Table Global Hemophilia Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Hemophilia Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Hemophilia Drugs Price Forecast by Type (2018-2025)
Table Global Hemophilia Drugs Consumption (K MT) Forecast by Application (2018-2025)
Figure Global Hemophilia Drugs Consumption (K MT) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • 2018-2023 Global Intravenous Immunoglobulin (IVIg) Consumption Market Report
    Published: 10-Aug-2018        Price: US 4660 Onwards        Pages: 160
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Intravenous Immunoglobulin (IVIg) market for 2018-2023. Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or "lot" of Intravenous Immunoglobulin. North America ......
  • Global Fibrinogen Concentrates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 09-Aug-2018        Price: US 3480 Onwards        Pages: 117
    Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer's product are justly used in local region or countries.......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Fibrinogen Concentrates Market 2018, Forecast to 2023
    Published: 09-Aug-2018        Price: US 4880 Onwards        Pages: 110
    Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer's product are justly used in local region or countries.......
  • Global Intravenous Immunoglobulin (IVIg) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 06-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or "lot" of Intravenous Immunoglobulin. Scope of the Report: This report focuses on the Intravenous Immunoglobulin (IVIg) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. Thi......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Intravenous Immunoglobulin (IVIg) Market 2018, Forecast to 2023
    Published: 06-Aug-2018        Price: US 4880 Onwards        Pages: 129
    Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or "lot" of Intravenous Immunoglobulin. Scope of the Report: This report focuses on the Intravenous Immunoglobulin (IVIg) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. Thi......
  • Global Heparin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 03-Aug-2018        Price: US 3480 Onwards        Pages: 132
    Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine Scope of the Report: This report focuses on the Heparin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Heparin Market 2018, Forecast to 2023
    Published: 03-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine Scope of the Report: This report focuses on the Heparin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and......
  • 2018-2023 Global Heparin Consumption Market Report
    Published: 02-Aug-2018        Price: US 4660 Onwards        Pages: 167
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Heparin market for 2018-2023. Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine He......
  • Global Fibrinogen Concentrates Market Professional Survey Report 2018
    Published: 01-Aug-2018        Price: US 3500 Onwards        Pages: 107
    This report studies the global Fibrinogen Concentrates market status and forecast, categorizes the global Fibrinogen Concentrates market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs